Results 11 to 20 of about 3,741,697 (242)

Batch Crystallization of Active Pharmaceutical Ingredient: Kinetics and Equilibrium Modelling [PDF]

open access: yesKemija u Industriji, 2018
Development of a mathematical model for batch crystallization of fesoterodine fumarate, an active pharmaceutical ingredient, in 2-butanone is presented.
Marko Trampuž   +2 more
doaj   +3 more sources

THE PROCEDURE OF ACTIVE PHARMACEUTICAL INGREDIENT SUPPLIERS PRELIMINARY CHOICE FOR MEDICINE MANUFACTURE [PDF]

open access: yesРазработка и регистрация лекарственных средств, 2019
The paper demonstrates application of the newly developed procedure for pre-selection of suppliers of active pharmaceutical ingredient to manufacture of drugs using the tools of risk analysis.
S. A. Zaitsev   +2 more
doaj   +1 more source

Structure of the active pharmaceutical ingredient bismuth subsalicylate [PDF]

open access: yes, 2021
Structure determination of pharmaceutical compounds is invaluable for drug development but is challenging for those that form as small crystals with defects.
A. Ken, Inge   +4 more
core   +2 more sources

STABILITY-INDICATING LC METHOD FOR THE QUANTIFICATION OF MIDAZOLAM ACTIVE PHARMACEUTICAL INGREDIENT AND IN PHARMACEUTICAL FORMULATIONS

open access: yesDrug Analytical Research, 2018
A stability-indicating LC method was validated for the quantification of midazolam (MDZ) active pharmaceutical ingredient (API) and in pharmaceutical formulations. Isocratic chromatography was performed on C18 column with mobile phase containing methanol/
Daiane Anzilaggo   +4 more
doaj   +9 more sources

Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation

open access: yesPharmaceutics, 2021
Improving dissolution properties of active pharmaceutical ingredients (APIs) is a critical step in drug development with the increasing occurrence of sparingly soluble APIs.
Hakyeong Kim, Soeun Jang, Il Won Kim
doaj   +1 more source

Computer-Aided Retrosynthesis for Greener and Optimal Total Synthesis of a Helicase-Primase Inhibitor Active Pharmaceutical Ingredient. [PDF]

open access: yesJACS Au
This study explores the application of computer-aided retrosynthesis (CAR) for developing greener and more efficient synthetic routes for the active pharmaceutical ingredient (API) IM-204, a helicase primase inhibitor with potential against Herpes ...
Teixeira RI   +3 more
europepmc   +3 more sources

Determination of active pharmaceutical ingredient – chloropyramine in dragées [PDF]

open access: yes, 2015
Chloropyramine is a first generation antihistamine drug approved in some Eastern European countries for the treatment of allergic conjunctivitis, allergic rhinitis, bronchial asthma, and other allergic conditions. Chloropyramine is known as a competitive
Gjorgjeska, Biljana   +2 more
core   +4 more sources

(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient

open access: yesActa Crystallographica Section E: Crystallographic Communications, 2020
The chiral title compound, C16H20N2O2, which can be used for producing active pharmaceutical ingredients for treatment of type 2 pancreatic diabetes and other pathologies dependent on insulin resistance, was prepared from (1R,3S)-camphoric acid and o ...
Sergiy M. Kovalenko   +4 more
doaj   +1 more source

Results for active pharmaceutical ingredient, pH and retention status.

open access: yes, 2021
Results for active pharmaceutical ingredient, pH and retention status.
Joyce M. Ondicho (11467141)   +3 more
core   +1 more source

Brazilian national production of active pharmaceutical ingredients: regulatory and strategic framework

open access: yesAnais da Academia Brasileira de Ciências, 2023
Active Pharmaceutical Ingredient (API) is any component of the final pharmaceutical product that serves as the active ingredient. The goal of the API Manufacturing is to produce APIs that are competitively priced and meet the quality standards with the ...
MARLON DANIEL L. TONINI   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy